These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18670196)

  • 21. Multiple antigen peptide consisting of B- and T-cell epitopes of F1 antigen of Y. pestis showed enhanced humoral and mucosal immune response in different strains of mice.
    Ali R; Kumar S; Naqvi RA; Sheikh IA; Rao DN
    Int Immunopharmacol; 2013 Jan; 15(1):97-105. PubMed ID: 23174507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranasal immunization with chitosan/pCETP nanoparticles inhibits atherosclerosis in a rabbit model of atherosclerosis.
    Yuan X; Yang X; Cai D; Mao D; Wu J; Zong L; Liu J
    Vaccine; 2008 Jul; 26(29-30):3727-34. PubMed ID: 18524427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic oligodeoxynucleotide containing CpG motif induces an anti-polysaccharide type 1-like immune response after immunization of mice with Haemophilus influenzae type b conjugate vaccine.
    von Hunolstein C; Teloni R; Mariotti S; Recchia S; Orefici G; Nisini R
    Int Immunol; 2000 Mar; 12(3):295-303. PubMed ID: 10700464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of nasal immunization of multi-target preventive vaccines on atherosclerosis.
    Jun L; Jie L; Dongping Y; Xin Y; Taiming L; Rongyue C; Jie W; Jingjing L
    Vaccine; 2012 Feb; 30(6):1029-37. PubMed ID: 22192848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccinating rabbits with a cholesteryl ester transfer protein (CETP) B-Cell epitope carried by heat shock protein-65 (HSP65) for inducing anti-CETP antibodies and reducing aortic lesions in vivo.
    Gaofu Q; Jun L; Xin Y; Wentao L; Jie W; Xiuyun Z; Jingjing L
    J Cardiovasc Pharmacol; 2005 Jun; 45(6):591-8. PubMed ID: 15897787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mucosal adjuvanticity of the oligodeoxynucleotides containing a non-methylated CpG motif on BCG and diphtheria toxoid.
    Maeyama J; Komiya T; Takahashi M; Isaka M; Goto N; Yamamoto S
    Vaccine; 2009 Feb; 27(8):1166-73. PubMed ID: 19136040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.
    Singh S; Yang G; Byrareddy SN; Barry MA; Sastry KJ
    Vaccine; 2014 Dec; 32(51):6934-6940. PubMed ID: 25444819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
    Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
    Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis.
    Rittershaus CW; Miller DP; Thomas LJ; Picard MD; Honan CM; Emmett CD; Pettey CL; Adari H; Hammond RA; Beattie DT; Callow AD; Marsh HC; Ryan US
    Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2106-12. PubMed ID: 10978256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.
    Radosević K; Rodriguez A; Mintardjo R; Tax D; Bengtsson KL; Thompson C; Zambon M; Weverling GJ; Uytdehaag F; Goudsmit J
    Vaccine; 2008 Jul; 26(29-30):3640-6. PubMed ID: 18514980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant properties of non-phospholipid liposomes (Novasomes) in experimental animals for human vaccine antigens.
    Gupta RK; Varanelli CL; Griffin P; Wallach DF; Siber GR
    Vaccine; 1996 Feb; 14(3):219-25. PubMed ID: 8920703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The controversy over the use of cholesteryl ester transfer protein inhibitors: is there some light at the end of the tunnel?
    Quintão EC
    Eur J Clin Invest; 2016 Jun; 46(6):581-9. PubMed ID: 26992444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
    Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
    BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
    San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
    Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant.
    La Rosa C; Longmate J; Lacey SF; Kaltcheva T; Sharan R; Marsano D; Kwon P; Drake J; Williams B; Denison S; Broyer S; Couture L; Nakamura R; Dadwal S; Kelsey MI; Krieg AM; Diamond DJ; Zaia JA
    J Infect Dis; 2012 Apr; 205(8):1294-304. PubMed ID: 22402037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phage-displayed recombinant single-chain antibody fragments with high affinity for cholesteryl ester transfer protein (CETP): cDNA cloning, characterization and CETP quantification.
    Ritsch A; Ebenbichler C; Naschberger E; Schgoer W; Stanzl U; Dietrich H; Heinrich PC; Saito K; Patsch JR
    Clin Chem Lab Med; 2004 Mar; 42(3):247-55. PubMed ID: 15080555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation, stability and immunogenicity of a trivalent pneumococcal protein vaccine formulated with aluminum salt adjuvants.
    Ljutic B; Ochs M; Messham B; Ming M; Dookie A; Harper K; Ausar SF
    Vaccine; 2012 Apr; 30(19):2981-8. PubMed ID: 22381074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancing immunogenicity of a 3'aminomethylnicotine-DT-conjugate anti-nicotine vaccine with CpG adjuvant in mice and non-human primates.
    McCluskie MJ; Pryde DC; Gervais DP; Stead DR; Zhang N; Benoit M; Robertson K; Kim IJ; Tharmanathan T; Merson JR; Davis HL
    Int Immunopharmacol; 2013 May; 16(1):50-6. PubMed ID: 23562759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity of HPV and HBV vaccines: adjuvanticity of synthetic analogs of monophosphoryl lipid A combined with aluminum hydroxide.
    Taleghani N; Bozorg A; Azimi A; Zamani H
    APMIS; 2019 Mar; 127(3):150-157. PubMed ID: 30746792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The co-administration of CpG-ODN influenced protective activity of influenza M2e vaccine.
    Wu F; Yuan XY; Li J; Chen YH
    Vaccine; 2009 Jul; 27(32):4320-4. PubMed ID: 19410621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.